Cybrexa Therapeutics has appointed Jaya Gautam, Ph.D., as Senior Vice President, Technical Operations.
“We are pleased to have Jaya join us at a pivotal point in the clinical development of our lead therapeutic, CBX-12, as we prepare to enter Phase 2 clinical trials,” said Per Hellsund, President and CEO of Cybrexa. “Jaya offers extensive experience in operations as well as peptide and small molecule manufacturing that strongly align with the needs of our evolving pipeline and our growing clinical and commercial objectives.”
Dr. Gautam joins several other recent company-wide hires, all of whom have been tasked with advancing and scaling CBX-12 into Phase 2 clinical trials and providing strategic support for the additional pipeline assets, like CBX-15, as the Cybrexa prepares for IND submission.